loadpatents
name:-0.008491039276123
name:-0.0063519477844238
name:-0.0010099411010742
Chappell; Mark Donald Patent Filings

Chappell; Mark Donald

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chappell; Mark Donald.The latest application filed is for "4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists".

Company Profile
0.7.12
  • Chappell; Mark Donald - Indianapolis IN
  • Chappell; Mark Donald - Noblesville IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists
Grant 9,056,844 - Dressman , et al. June 16, 2
2015-06-16
4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS
App 20130237573 - Dressman; Bruce Anthony ;   et al.
2013-09-12
Glucagon receptor antagonists, preparation and therapeutic uses
Grant 8,084,489 - Chappell , et al. December 27, 2
2011-12-27
Glucagon receptor antagonists, preparation and therapeutic uses
Grant 8,076,374 - Chappell , et al. December 13, 2
2011-12-13
Glucagon receptor antagonists, preparation and therapeutic uses
Grant 7,989,457 - Chappell , et al. August 2, 2
2011-08-02
Opioid Receptor Antagonists
App 20110105571 - Chappell; Mark Donald ;   et al.
2011-05-05
Opioid receptor antagonists
Grant 7,902,372 - Chappell , et al. March 8, 2
2011-03-08
Substituted thiophene carboxylic amide glucagon receptor antagonists, preparation and therapeutic uses
Grant 7,807,702 - Chappell , et al. October 5, 2
2010-10-05
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
App 20100137417 - Chappell; Mark Donald ;   et al.
2010-06-03
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
App 20080319074 - Chappell; Mark Donald ;   et al.
2008-12-25
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
App 20080300289 - Chappell; Mark Donald ;   et al.
2008-12-04
Diaryl Ethers As Opioid Receptor Antagonists
App 20080269296 - Blanco-Pillado; Maria-Jesus ;   et al.
2008-10-30
Diaryl Ethers As Opioid Receptor Antagonists
App 20080255152 - Blanco-Pillado; Maria-Jesus ;   et al.
2008-10-16
Opioid Receptor Antagonists
App 20080207701 - Chappell; Mark Donald ;   et al.
2008-08-28
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
App 20080125468 - Chappell; Mark Donald ;   et al.
2008-05-29
Opioid Receptor Antagonists
App 20070066658 - Chappell; Mark Donald
2007-03-22
Diaryl ethers as opioid receptor antagonist
App 20060217372 - Blanco-Pillado; Maria-Jesus ;   et al.
2006-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed